Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Surgical snares are surgical instruments equipped with a wire loop, which are controlled by a mechanism in the handle and used to remove growths, such as tumors and polyps. It has an operating loop formed with a resilient spiral sleeve through which a core member extends. Various types of surgical snares have been employed for a number of years to remove polyps from the colon and rectum. Advances have been made whereby surgical snares have been introduced through the elongated bore of a colonoscope. The Olympus single-use snare line-up includes standard oval snares, crescent shaped snares, hard wire oval snares and soft wire oval snares. Snares with various loop shapes and wire characteristics are needed for different application areas for e.g. hard snares for flat polyps or thick wires for higher coagulation effect.
The global surgical snare market is observing significant growth owing to increasing number for colon polypectomy procedures, growth of the endoscopic ambulatory surgical centers. The market is further boosted by surging demand for minimally invasive procedures due to the benefits, such as less trauma, speedy recovery, along with technological advancements in of surgical snare. In addition, increasing per capita income is enabling people to take up advanced surgical procedures, thus driving the growth of this market. Active role of healthcare agencies and government in creating awareness about various diseases is also expected to facilitate usage of surgical snares, thereby supporting market development. However, the market is hindered by dearth of trained physicians and endoscopists.
The report analyses the global surgical snare market based on usability, application, end user and geography.
Based on usability, the market is categorized into reusable and single use. Reusable surgical snares are conventional instruments that are used for polyp and tumor removal in endoscopy procedures. These instruments are more cost-effective as compared to disposable instruments and help reduce the cost of endoscopy procedures.
The surgical snare market offers applications in GI endoscopy, laparoscopy, gynecology/obstetrics endoscopy, arthroscopy, urology endoscopy, bronchoscopy, mediastinoscopy, otoscopy, laryngoscopy, retinal endoscopy, neuroendoscopy and other applications such as endoscopic tonsillectomy, retinal endoscopy, rhinoscopy, neuroendoscopy, and thoracoscopy. Arthroscopy is a minimally invasive surgical procedure on a joint performed using an arthroscope, an endoscope that is inserted into the joint through a small incision.
Furthermore, various end users of this market are categorized into hospitals, ambulatory surgical centers and clinics. The hospitals comprises surgical units based in hospitals or attached to hospitals that are equipped with endoscopic instruments and accessories, including surgical snares, to perform endoscopic procedures for diagnostic or treatment purposes.
By geography, the global surgical snare market is studied across the countries of key regions such as, North America, Europe, Asia Pacific and rest of the world. In 2018, North America held the largest revenue share mainly due to factors such as government support for quality healthcare, high purchasing power parity, availability of reimbursement, and increasing prevalence of cancers in U.S. and Canada. Furthermore, Asia Pacific is expected to witness lucrative growth over the forecast period owing to supportive government initiatives and improving healthcare infrastructure. Additionally, economic developments in countries, such as India and China, are expected to help spur the market growth. Huge population base with low per capita income in the region led to high demand for affordable treatment options.
The leading surgical snare market players are Avalign Technologies, Boston Scientific, CONMED, Cook Medical, Hill-Rom Holdings, Medline Industries, Medtronic PLC, Merit Medical Systems, Olympus, Sklar Surgical Instruments and Steris. These companies have adopted various strategies, such as new product launches, collaborations, technological advancements, M&A, to sustain their position in the market. For instance, In February 2017, Merit Medical Systems acquired the critical care product portfolio of Argon Medical Devices and Catheter Connections, Inc. This acquisition has helped the company to broaden its product offerings and expand geographic presence in the surgical snare market.
The global surgical snare market is segmented based on usability, application, end user and geography. Based on usability, the market is categorized into reusable and single use. Reusable surgical snares are conventional instruments that are used for polyp and tumor removal in endoscopy procedures.
The surgical snare market offers applications in GI endoscopy, laparoscopy, gynecology/obstetrics endoscopy, arthroscopy, urology endoscopy, bronchoscopy, mediastinoscopy, otoscopy, laryngoscopy, retinal endoscopy, neuroendoscopy and other applications such as endoscopic tonsillectomy, retinal endoscopy, rhinoscopy, neuroendoscopy, and thoracoscopy.
Furthermore, various end users of this market are categorized into hospitals, ambulatory surgical centers and clinics. The hospitals comprises surgical units based in hospitals or attached to hospitals that are equipped with endoscopic instruments and accessories, including surgical snares, to perform endoscopic procedures for diagnostic or treatment purposes.
By geography, the global surgical snare market is studied across the countries of key regions such as, North America, Europe, Asia Pacific and rest of the world. In 2018, North America held the largest revenue share mainly due to factors such as government support for quality healthcare, high purchasing power parity, availability of reimbursement, and increasing prevalence of cancers in U.S. and Canada.
Why to buy this report:
